Pieris Pharmaceuticals Inc buy BiotechBee
Start price
02.01.23
/
60%
€1.04
Target price
31.12.25
€3.00
Performance (%)
-26.41%
End price
05.05.23
€0.77
Summary
This prediction ended on 05.05.23 with a price of €0.77. The prediction for Pieris Pharmaceuticals Inc disappointed with a performance of -26.41%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pieris Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
According to BiotechBee what are the pros and cons of Pieris Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Pieris Pharmaceuticals Inc diskutieren
Buy mit Kursziel 3,0
In the thread Trading Pieris Pharmaceuticals Inc
Buy beendet

